Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

References

• OgleGBeranDRaabRDeebLOn behalf of the Task Force on Insulin, Test Strips and Other Diabetes Supplies. Global access to and availability of insulinDiabetes Voice2006512225
   Google Scholar
• HirschIBInsulin analoguesN Engl J Med200535217418315647580
   PubMed Web of Science ®Google Scholar
• HeiseTPieberTRTowards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studiesDiabetes Obes Metab2007564865917645556
   PubMedGoogle Scholar
• JehlePMMichelerCJehleDRInadequate suspension of neutral protamine Hagendorn (NPH) insulin in pensLancet19993541604160710560676
   PubMed Web of Science ®Google Scholar
• LargerEWeight gain and insulin treatmentDiabetes Metab2005314S514S5616389899
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRLauritzenTResistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) studyDiabetes Care2005282673267916249538
   PubMed Web of Science ®Google Scholar
• BarnettAHInsulin glargine in the treatment of type 1 and type 2 diabetesVasc Health Risk Manag20062596717319470
   PubMedGoogle Scholar
• HavelundSPlumARibelUThe mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulinPharm Res2004211498150415359587
   PubMed Web of Science ®Google Scholar
• PhilipsJCScheenAInsulin detemir in the treatment of type 1 and type 2 diabetesVasc Health Risk Manag2006227728317326333
   PubMedGoogle Scholar
• HeiseTNosekLRønnBBLower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetesDiabetes2004531614162015161770
   PubMed Web of Science ®Google Scholar
• RosenstockJDaileyGMassi-BenedettiMReduced Hypoglycemia Risk With Insulin Glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetesDiabetes Care20052895095515793205
   PubMed Web of Science ®Google Scholar
• HermansenKDaviesMDerezinskiTA 26-week, randomized parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetesDiabetes Care2006291269127416732007
   PubMed Web of Science ®Google Scholar
• ChatterjeeSJarvis-KayJRengarajanTGlargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes – the glargine and aspart study (GLASS) a randomised cross-over studyDiabetes Res Clin Pract20077721522217141354
   PubMed Web of Science ®Google Scholar
• BartleyPCBogoevMLarsenJLong-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trialDiabet Med20082544244918387078
   PubMed Web of Science ®Google Scholar
• Report No. 18 to the Storting (2004–2005). On course towards more correct use of medicine – Medicinal Product Policy. Accessed Nov 13th 2008.URL: http://www.regjeringen.no/Upload/HOD/Dokumenter%20LMS/Utdrag%20fra%20legemiddelmeldingen%20oversatt%20til%20engelsk.pdf
   Google Scholar
• LevorsenAKristiansenISAaslandOGPhysicians’ experience with increased use of individual reimbursement for pharmaceuticalsTidsskr Nor Laegeforen20081281829183218787593
   PubMedGoogle Scholar
• The Norwegian Labour and Welfare Organisation 2008. Accessed Sept 6th 2008. URL: http://rundskriv.nav.no/rtv/lpext.dll?f=templates&fn=main-j.htm&2.0
   Google Scholar
• Workgroup on Hypoglycemia, American Diabetes AssociationDefining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on HypoglycemiaDiabetes Care2005281245124915855602
   PubMed Web of Science ®Google Scholar
• KanazawaYIgarashiYKomiyaKLong-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2)Endocr J20075497598318000343
   PubMed Web of Science ®Google Scholar
• PäivärintaMTapanainenPVeijolaRBasal insulin switch from NPH to glargine in children and adolescents with type 1 diabetesPediatr Diabetes20089839018221431
   PubMed Web of Science ®Google Scholar
• PieberTRTreichelH-CHompeschBComparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyDiabet Med20072463564217381500
   PubMed Web of Science ®Google Scholar
• www.novonordisk-trials.com 2008 Safety and efficacy of insulin detemir plus insulin aspart against insulin glargine plus insulin aspart as mealtime insulin in type 1 diabetes. Accessed May 8th 2008. URL: http://www.novonordisk-trials.com/website/search/trial-result-details.aspx?id=1057&p=1&search=t ()
   Google Scholar
• CurrieCJPooleCDTetlowTThe outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysisCurr Med Res Opin200723S13339
   Google Scholar
• DornhorstALüddekeHJHonkaMSafety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE studyCurr Med Res Opin20082436937618096110
   PubMed Web of Science ®Google Scholar
• VardiMJacobsonENiniABittermanHIntermediate acting versus long acting insulin for type 1 diabetes mellitusCochrane Database Syst Rev2008163CD00629718646147
   PubMedGoogle Scholar
• UK Hypoglycaemia Study GroupRisk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their durationDiabetologia2007501140114717415551
   PubMed Web of Science ®Google Scholar
• AlbrightESDesmondRBellDSEfficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapyDiabetes Care20042763263314747268
   PubMed Web of Science ®Google Scholar
• AshwellSGGebbieJHomePDTwice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspartDiabet Med20062387988616911626
   PubMed Web of Science ®Google Scholar
• GargSGottliebPAHisatomiMEImproved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargineDiab Res Clin Pract2004664956
   PubMed Web of Science ®Google Scholar
• NathanDMClearyPABacklundJYIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesN Engl J Med20053532643265316371630
   PubMed Web of Science ®Google Scholar
• AshwellSGBradleyCStephensJWTreatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in people with Type 1 diabetesDiabetes Care2008311112111718339977
   PubMed Web of Science ®Google Scholar